Search | IOVS | ARVO Journals

Showing 1 – 20 of 41

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina December 2024

Retinal Docosahexaenoic Acid Is Significantly Reduced in Diabetic Humans and Mice: Possible Relationship to Diabetic Retinopathy

PDF

Dhavamani Sugasini; Poorna C. R. Yalagala; Jason C. Park; Guangying Ma; Zeenat Farooq; Basma Baccouche; Onkar B. Sawant; J. Jason McAnany; Xincheng Yao; Andrius Kazlauskas; Brian T. Layden; Papasani V. Subbaiah
TAGS: diabetes mellitus, diabetic retinopathy, fatty acids, mice, retina, docosahexaenoic acids, electroretinography
Invest. Ophthalmol. Vis. Sci.. 2024; 65(14):39. https://doi.org/10.1167/iovs.65.14.39

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Activin attenuates VEGF-induced permeability by multiple mechanism that are determined by the duration of exposure to activin

Basma Baccouche; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):877.

ARVO Annual Meeting Abstract June 2024

Identification of transcriptional changes that mediate permeability in response to both VEGF and cytokines

Maximilian McCann; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):876.

ARVO Annual Meeting Abstract June 2023

Response Rate to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema Patients Treated with Systemic Renin-Angiotensin-Aldosterone System Antagonists

Daniel E. Maidana; Eyad Hamad; Mark C. Perkowski; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):557.

ARVO Annual Meeting Abstract June 2023

The onset of diabetes is associated with protection of retinal vessels from death

Yanliang li; Norma Del-Risco; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1235.

ARVO Annual Meeting Abstract June 2023

Activin A attenuates VEGF-mediated permeability via VE-PTP

Basma Baccouche; Lina Lietuvninkas; Yueru Li; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1833.

ARVO Annual Meeting Abstract June 2023

VEGF induces expression of genes that either promote, or limit relaxation of the retinal endothelial barrier

Maximilian McCann; Yueru Li; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1809.

ARVO Annual Meeting Abstract June 2022

Hyperglycemia promotes mitophagy and thereby mitigates hyperglycemia-induced damage

Anara Serikbaeva; Ruth Zelkha; Destiny Ogbu; Yueru Li; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3621 – A0076.

ARVO Annual Meeting Abstract June 2022

Activin A limits VEGF-induced permeability

Basma Baccouche; Lina Lietuvninkas; Yueru Li; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3602 – A0057.

ARVO Annual Meeting Abstract June 2022

Hyperglycemia alters VEGF-induced permeability in retinal endothelial cells

Maximilian McCann; Yueru Li; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3594 – A0049.

Retinal Cell Biology September 2021

The Role of the Wnt Pathway in VEGF/Anti-VEGF-Dependent Control of the Endothelial Cell Barrier

PDF

Yueru Li; Basma Baccouche; Olamide Olayinka; Anara Serikbaeva; Andrius Kazlauskas
TAGS: endothelial cells, permeability, vascular endothelial growth factor a, anti-vascular endothelial growth factor therapy, endothelium, signal transduction
Invest. Ophthalmol. Vis. Sci.. 2021; 62(12):17. https://doi.org/10.1167/iovs.62.12.17

Includes: Supplemental Content

Physiology and Pharmacology February 2021

VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration

PDF

Stephen B. Waters; Christopher Zhou; Tara Nguyen; Ruth Zelkha; Hyun Lee; Andrius Kazlauskas; Mark I. Rosenblatt; Asrar B. Malik; Kaori H. Yamada
TAGS: choroidal neovascularization, exudative age-related macular degeneration, eyedrops, lasers, mice, peptides, vascular endothelial growth factor receptor-2, neovascularization, pathologic, eye, antibodies
Invest. Ophthalmol. Vis. Sci.. 2021; 62(2):5. https://doi.org/10.1167/iovs.62.2.5

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

The Renin-Angiotensin-Aldosterone System (RAAS) is One of the Effectors used by VEGF/anti-VEGF to Control the Endothelial Cell Barrier.

Yueru Li; Komal Chaudhry; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):297.

Cornea February 2017

PDGFRα Is a Key Regulator of T1 and T3's Differential Effect on SMA Expression in Human Corneal Fibroblasts

PDF

Sriniwas Sriram; Jennifer A. Tran; Xiaoqing Guo; Audrey E. K. Hutcheon; Hetian Lei; Andrius Kazlauskas; James D. Zieske
TAGS: cell lines, cornea, fibroblasts, fluorescent antibody technique, transforming growth factor beta3, platelet-derived growth factor, polymerase chain reaction, growth factor, protein isoforms, transcription, genetic
Invest. Ophthalmol. Vis. Sci.. 2017; 58(2):1179-1186. https://doi.org/10.1167/iovs.16-20016

ARVO Annual Meeting Abstract September 2016

Identifying the role of PDGFRα in the fibrotic pathway of TGF-β3

Sriniwas Sriram; Jennifer A Tran; Xiaoqing Q Guo; Hetian Lei; Andrius Kazlauskas; James D Zieske

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2355.

Biochemistry and Molecular Biology July 2016

Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases

PDF

Gaoen Ma; Yajian Duan; Xionggao Huang; Cynthia X. Qian; Yewlin Chee; Shizuo Mukai; Jing Cui; Arif Samad; Joanne Aiko Matsubara; Andrius Kazlauskas; Patricia A. D'Amore; Shuyan Gu; Hetian Lei
TAGS: mice, oryctolagus cuniculus, phosphates, phosphatidylinositols, phosphotransferases, prevention, vitreoretinopathy, proliferative, vitreous body, western blotting, cell proliferation
Invest. Ophthalmol. Vis. Sci.. 2016; 57(8):3935-3943. https://doi.org/10.1167/iovs.16-19405

ARVO Annual Meeting Abstract June 2015

PDGFRα is required for the anti-fibrotic action of TGFβ3

Sriniwas Sriram; Jennifer A Tran; Xiaoqing Q Guo; Andrius Kazlauskas; James D Zieske

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):719.

ARVO Annual Meeting Abstract June 2015

A Role of Phosphatidylinoitol 5-Phosphate 4-Kinases in Proliferative Vitreoretinopathy

Hetian Lei; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):398.

ARVO Annual Meeting Abstract June 2015

Development and Characterization of a new Mouse Model of Proliferative Diabetic Retinopathy

Ashley Michael Mackey; Jorge Aranda; Chiara Gerhardinger; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4676.

ARVO Annual Meeting Abstract June 2015

AMD-Associated Silent Substitutions in HTRA1 Hijack the Unfolded Protein Response in RPE

Sarah Melissa Porras Jacobo; Andrius Kazlauskas

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2596.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Retinal Docosahexaenoic Acid Is Significantly Reduced in Diabetic Humans and Mice: Possible Relationship to Diabetic Retinopathy

Activin attenuates VEGF-induced permeability by multiple mechanism that are determined by the duration of exposure to activin

Identification of transcriptional changes that mediate permeability in response to both VEGF and cytokines

Response Rate to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema Patients Treated with Systemic Renin-Angiotensin-Aldosterone System Antagonists

The onset of diabetes is associated with protection of retinal vessels from death

Activin A attenuates VEGF-mediated permeability via VE-PTP

VEGF induces expression of genes that either promote, or limit relaxation of the retinal endothelial barrier

Hyperglycemia promotes mitophagy and thereby mitigates hyperglycemia-induced damage

Activin A limits VEGF-induced permeability

Hyperglycemia alters VEGF-induced permeability in retinal endothelial cells

The Role of the Wnt Pathway in VEGF/Anti-VEGF-Dependent Control of the Endothelial Cell Barrier

VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration

The Renin-Angiotensin-Aldosterone System (RAAS) is One of the Effectors used by VEGF/anti-VEGF to Control the Endothelial Cell Barrier.

PDGFRα Is a Key Regulator of T1 and T3's Differential Effect on SMA Expression in Human Corneal Fibroblasts

Identifying the role of PDGFRα in the fibrotic pathway of TGF-β3

Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases

PDGFRα is required for the anti-fibrotic action of TGFβ3

A Role of Phosphatidylinoitol 5-Phosphate 4-Kinases in Proliferative Vitreoretinopathy

Development and Characterization of a new Mouse Model of Proliferative Diabetic Retinopathy

AMD-Associated Silent Substitutions in HTRA1 Hijack the Unfolded Protein Response in RPE

To View More...

You must be signed into an individual account to use this feature.